https://orcid.org/0000-0002-2758-1437
Figures
Abstract
Background
We examined the impact of the Clonorchis sinensis (C. sinensis) infection on the survival outcomes of spontaneous rupture Hepatocellular Carcinoma (srHCC) patients undergoing hepatectomy.
Methods
Between May 2013 and December 2021, 157 consecutive srHCC patients who underwent hepatectomy were divided into an no C. sinensis group (n = 126) and C. sinensis group (n = 31). To adjust for differences in preoperative characteristics an inverse probability of treatment weighting (IPTW) analysis was done, using propensity scores. Overall survival (OS) and recurrence-free survival (RFS) were compared before and after IPTW. Multivariate Cox regression analysis was performed to determine whether the C. sinensis infection was an independent prognostic factor after IPTW.
Results
In original cohort, the no C. sinensis group did not show a survival advantage over the C. sinensis group. After IPTW adjustment, the median OS for the C. sinensis group was 9 months, compared to 29 months for the no C. sinensis group. C. sinensis group have worse OS than no C. sinensis group (p = 0.024), while it did not differ in RFS(p = 0.065). The multivariate Cox regression analysis showed that C. sinensis infection and lower age were associated with worse OS.
Author summary
Clonorchis sinensis, a trematode of the Opisthorchiidae family, is a genus of zoonotic parasite and liver fluke. This species specifically resides in the bile ducts of humans and mammals during its adult stage. Known as a class I carcinogen by the International Agency for Research on Cancer, Clonorchis sinensis has gained recognition for its association with cholangiocarcinoma. The occurrence of Clonorchis sinensis and its transmission to humans heavily relies on geographical factors and the dietary preferences of its hosts. Individuals, along with other definitive hosts, contract the parasite by consuming raw or undercooked freshwater fish or shrimp that harbor infective metacercariae. A study indicated that patients with hepatocellular carcinoma combined with Clonorchis sinensis infection have a worse prognosis after hepatectomy. This study aimed to determine the prognostic significance of Clonorchis sinensis infection with spontaneous rupture Hepatocellular Carcinoma(srHCC). We have retrospectively analyzed the infection rate of srHCC. We found that 19.7% of patients with srHCC had a combination of Clonorchis sinensis infection. We also found that srHCC patients with Clonorchis sinensis infection have a worse prognosis after hepatectomy. This is a single center study, hopefully lending guidance the prognosis of srHCC with Clonorchis sinensis.
Citation: Ni H-H, Lu Z, Yang C-L, Lv Y-T, Lu C-X, Xiang B-D (2024) Clonorchis sinensis on the prognosis of patients with spontaneous rupture of Hepatocellular Carcinoma: An inverse probability of treatment weighting analysis. PLoS Negl Trop Dis 18(2): e0011987. https://doi.org/10.1371/journal.pntd.0011987
Editor: Javier Sotillo, Instituto de Salud Carlos III, SPAIN
Received: July 31, 2023; Accepted: February 12, 2024; Published: February 21, 2024
Copyright: © 2024 Ni et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting Information files.
Funding: BDX received the financial support from the National Natural Science Foundation of China (grant no. 81960450), the National Major Special Science and Technology Project (grant no. 2017ZX10203207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer-related deaths worldwide and with the highest incidence in Asia, especially in China [1]. Spontaneous rupture of hepatocellular carcinoma (srHCC) is a special type of HCC with the incidence of 2.3–26% [2,3], and mortality is 25–75% [4]. The mechanisms of srHCC remain unclear. Possible reasons include large tumor size, ischemic necrosis, and vascular compression caused by rapid tumor growth [5–7].
Clonorchiasis, which is caused by the parasitic zoonosis known as Clonorchis sinensis (C. sinensis), is a major health concern in Asia. It is estimated that around 35 million individuals are infected with this disease, with approximately 15 million of these cases being reported in China alone [8–10]. The region most severely impacted by this affliction are Guangdong Province and the Guangxi Zhuang Autonomous Region in Southern China [11–13]. C. sinensis transmission occurs when individuals ingest raw or undercooked fish that is contaminated with C. sinensis metacercariae [14]. One study confirmed that C. sinensis could aggravate the progression of liver fibrosis [15]. Our study demonstrated that C. sinensis infection increases risk of HCC in a rat model [16]. Our clinical study also revealed that HCC with C. sinensis infection experience a poor prognosis after hepatectomy [17]. However, no study has reported an association between C. sinensis infection and the prognosis of srHCC. To our knowledge, the prognosis of srHCC remain controversial as yet, only a small number of studies have been conducted to determine the prognostic factors for postoperative survival. Therefore, it is necessary to study whether C. sinensis infection affects the prognosis of srHCC after hepatectomy.
Observational studies, which gather data from routine clinical practice, offer valuable insights into the effects of treatments on a broader range of patients and over a longer period of time. However, these studies may be susceptible to confounding by indications, as inherent differences between treatment groups can make it difficult to reliably estimate the treatment effect by directly comparing outcomes [18]. To address this issue, the use of inverse probability of treatment weighting (IPTW) has gained popularity. This statistical approach, based on propensity scores, has been demonstrated to result in more robust and less biased estimates of treatment effects [19].
In this study, we therefore conducted this retrospective study to analyze C. sinensis associated with the recurrence free survival (RFS) and overall survival (OS) of HCC patients with spontaneous rupture after hepatectomy via IPTW method.
Materials and methods
Ethics statement
The study was conducted according to the principles of the Declaration of Helsinki and was approved by the Ethics Committee of the Affiliated Cancer Hospital of Guangxi Medical University (Approval No.: LW2024004). Individual consent for this retrospective analysis was waived.
Study population
This is a retrospective study at the Affiliated Cancer Hospital of Guangxi Medical University in Nanning, Guangxi Zhuang Autonomous Region, China, between May 2013 and December 2021. Of 328 patients with ruptured HCC, 171 were excluded (17 with previous treatment, 95 receiving TAE or TACE, 33 without treatment, and 26 without complete follow up data). A total of 157 patients were included in the analysis, of which 31 patients with C. sinensis and 126 patients without C. sinensis. (Fig 1).
TACE, transcatheter arterial chemoembolization; TAE, transcatheter arterial embolization.
Definition
The diagnostic criteria for clonorchiasis are specified below, and the confirmation of Clonorchis Sinensis diagnosis required the presence of any one factor [14,20,21]. (1) Clinical diagnosis cases: In order to qualify for this type of diagnosis, the patient must have a history of eating raw or half-raw freshwater fish or shrimp, and should have a record of living, working, or traveling in endemic areas. Additionally, there should be a noticeable but mild expansion in the intrahepatic bile ducts, which can be detected through imaging (CT, MRI, or ultrasonography can determine the pattern of bile duct expansion). It should be noted that any locally induced expansion due to factors such as bile duct stones, cancerous embolism, tumor compression, or thrombosis will not be considered. (2) The presence of adult C. sinensis in the liver or gallbladder is confirmed through intraoperative or postoperative pathological examination. (3) Preoperative fecal examination has given a positive result in detecting C. sinensis eggs. The diagnosis of srHCC relies on the manifestation of symptoms that include acute abdominal pain and signs of peritonitis, which will be confirmed through contrast-enhanced CT or MRI scans that detect the extravasation of contrast materials from the tumor’s surrounding perihepatic hematoma and signs of peritoneal effusion. When necessary, diagnostic abdominal paracentesis is performed to further validate the diagnosis. The presence of srHCC will be confirmed by intraoperative observations of tumor rupture with hemoperitoneum and postoperative pathology, or contrast medium extravasation in angiography.
Treatment
The objective of performing partial hepatectomy was to remove all detectable cancerous tissue. All operative procedures were performed by experienced surgeons, and the abdominal cavity was extensively explored during the operation. The desirable tumor margin during resection was more than 1 cm. To prevent the spread of tumor cells, a significant quantity of distilled water was used to cleanse the peritoneum. Anthelmintic therapy was not administered to srHCC patients with C. sinensis before or after surgery, and deworming was only done if the patient volunteered for anthelmintic therapy.
Patient Follow-Up
Patients were followed-up at one month after the operation and subsequently every three months for the first two years, every six months thereafter. Laboratory examinations (serum AFP, liver function, blood tests), abdominal ultrasonography, and contrast-enhanced CT were collected. Follow-up period was terminated on March, 2023. The diagnosis of recurrence was based on typical findings of HCC on CT or MR imaging.
Statistical analysis
To minimize the potential bias caused by confounding factors, we utilized stabilized inverse probability of treatment weights (IPTW), a propensity score-based method used to balance baseline variables without sample loss. To achieve this, we employed a logistic regression model that encompassed all available covariates. We aimed to prevent an unintended imbalance in other parameters that may not directly correlate with the probability of receiving the treatment but could still have an unknown impact on the outcome. The obtained propensity score was then used to generate IPTW through appropriate math, which were used to weight each clinical feature, as well as measured outcomes, of each patient in both treatment groups [22,23].
RFS was measured from the date of hepatectomy until tumor recurrence. Overall survival (OS) was measured between the date of hepatectomy and the date of death or the date of the last follow-up visit. RFS and OS was evaluated using the Kaplan–Meier method and compared with the log-rank test. The variables with statistical significance were firstly identified by the univariate Cox regression (P<0.05), and then were analyzed by the multivariate cox regression. Statistical analyses were performed using SPSS 26.0 (IBM, Chicago, IL, USA) and R software version 4.1.2 (http://www.R-project.org), and a two-sided p< 0.05 denoted statistically significant.
Results
Baseline characteristics
A total of 157 patients were included in this study; of which 31(19.7%) patients with C. sinensis, 126(80.3%) without C. sinensis. There were 135(80.0%) patients with HbsAg and 22(20.0%) without. The median age is 50 years. This study included 133 (84.7%) men and 24 (15.3%) women. Table 1 shows the baseline characteristics of the two study groups before and after IPTW. In the original cohort, there were significant differences with respect to male, HbsAg, Liver cirrhosis, Edmondson stage, AST, PLT, Tumor number and MVI(SMD>0.2). A good covariate balance was achieved after the application of IPTW; the only exception was HbsAg (SMD >0.2).
Overall survival and recurrence-free survival before matching
Fig 2 shows the OS and RFS curves for the patients with or without C. sinensis before matching. The median OS for the C. sinensis group was 17 months while that for the no C. sinensis group was 32 months. The 1, 3 and 5-year OS rates for the C. sinensis group were 64.5%, 39.6% and 26.4%, respectively, whereas those for the no C. sinensis group were 72.4%, 46.3% and 37.6%, respectively, with no significant difference between the two groups (p = 0.204). In terms of RFS, the median for the C. sinensis group was 10 months, while that for the no C. sinensis group was 9 months. The 1, 3 and 5-year RFS rates for the C. sinensis group were 38.7%, 10.9%, and 5.5% respectively, while those for the no C. sinensis group were 44.4%, 27.3% and 21.2%, respectively. However, there was no significant difference between the two groups (p = 0.264).
Recurrence-free survival (RFS) and Overall survival (OS) curves before matching. The RFS curve (A) and the OS curve (B).
Overall survival and recurrence-free survival after inverse probability of treatment weighting analysis
After adjusting for potential confounders using inverse probability of treatment weighting (IPTW), following the analysis, the median RFS for the C. sinensis group was noted to be 6 months, while that for the no C. sinensis group was observed to be 8 months, there was no significant difference in RFS between the two groups (p = 0.065). Similarly, the median OS for the C. sinensis group was found to be 9 months, compared to 29 months for the no C. sinensis group, there was significant difference in OS between the two groups (p = 0.024) (Fig 3).
The RFS curve (A) and OS curve (B).
C. sinensis and HBV co-infection Prognostic analysis
24 patients were co-infected with C. sinensis and HBV, the other 133 patients included 7 C. sinensis infections alone, 111 HBV infections alone, and 15 double negative patients. There was no significant difference in RFS between the C. sinensis-positive + HBV-positive group and others group before and after IPTW. Similarly, there was no significant difference in OS between the two groups before and after IPTW (Fig 4).
The PFS curve(A) and OS curve(B) before inverse probability of treatment weighting analysis. The PFS curve(C) and OS curve (D) after inverse probability of treatment weighting analysis. C. sinensis, Clonorchis sinensis; HBV, Hepatitis B virus.
Prognostic factors associated with Overall survival after inverse probability of treatment weighting
After IPTW weighting, C. sinensis infection and Age ≤50 years were shown to be associated with Overall survival risk in the univariate analysis(p<0.05). Multivariate Cox regression analyses demonstrated that C. sinensis infection (HR = 1.930) and Age ≤50 years (HR = 1.869) were independent prognostic factors for OS(p<0.05). (Table 2)
Discussion
Supported by IPTW and multivariate Cox regression analyses, our findings suggest that C. sinensis infection serves as an independent prognostic indicator for OS in patients with srHCC, and is associated with increased mortality rates. While no significant impact on RFS was observed, a clear trend towards higher relapse rates was noted. The weight assigned to each patient in the cohort is determined by their probability of exposure to the C. sinensis being studied. Once the treatment groups are balanced, applying weights during statistical tests or regression models helps mitigate or eliminate the influence of known confounding factors.
To the best of our knowledge, no previous cohort study has investigated the association between C. sinensis infection and srHCC in the overworld population. C. sinensis are prevalent in our region. One study reported that C. sinensis is an important risk factor for ICC and HCC in a high prevalence area [24]. Prior research indicated that certain molecules have the potential to significantly inhibit apoptosis, as well as stimulate the proliferation and migration of human HCC cells. These effects may potentially exacerbate the progression of HCC in patients who are also infected with C. sinensis [25,26]. Patients diagnosed with HCC and co-existing C. sinensis infection typically face a grim outlook following hepatectomy. This study revealed that C. sinensis infection does not affect RFS and OS with surgery for srHCC before IPWT. However, after IPTW, patients with srHCC infected with C. sinensis have a worse OS. The most likely reason is that before IPTW matching, the baseline characteristics of the patients between two group was unbalanced. Our pervious study has demonstrated that patients with HCC and C. sinensis infection experience a poor prognosis after hepatectomy, but C. sinensis is not an independent risk factor affecting OS [17]. This study demonstrated that C. sinensis infection is an independent prognostic factor affecting the OS of patients with srHCC. The utilization of the IPTW technique, which is a comparatively innovative approach in the area under discussion, produced a weighted sample that has a more balanced distribution of covariates between the C. sinensis group and the no C. sinensis group. This allowed us to not only minimize the discrepancies in patient features but also maintain the sample size and statistical potency, leading to a more refined and accurate assessment of the treatment impact.
In China, individuals with HBV infections are frequently located in regions with a high occurrence of C. sinensis [24,27]. The hepatitis B virus is serious pathogen that can cause liver disease and cancer. Study demonstrated that the simultaneous presence of HBV and C. sinensis could have a detrimental effect on liver function and potentially facilitate the proliferation of HBV [28]. This study showed that co-infection of C. sinensis and HBV did not affect the prognosis of patients, possibly because most of the patients in the study were infected with HBV. C. sinensis infection may only promote HBV proliferation, and C. sinensis cannot directly affect the prognosis of hepatocellular carcinoma.
Age was found to be a significant parameter associated with survival in our study. Specifically, we found that srHCC patients with lower age had a worse prognosis. This finding is consistent with previous research results [29–31]. Some studies have found that young HCC patients have better prognosis because they have better liver function [32–35]. However, others have reported that young patients with advanced tumor factors, have a poor prognosis [36–38]. According to the current eighth edition of the AJCC/UICC (American Joint Committee on Cancer/Union for International Cancer Control) classification [39], srHCC is defined as a T4 stage tumor, which is an advanced tumor factor. Our research results also suggest that age is an independent risk factor affecting OS of srHCC patients.
This study has some limitations. Firstly, due its retrospective nature, and the confounding effects between the two groups could not be completely excluded after IPTW analyses. On the other hand, because the underlying liver disease in the present study was chronic hepatitis B infection in most patients, the results should be validated in other study groups with HCV infections or alcohol consumption. Thirdly, this is a single center and small sample analysis, and selection bias was present due to the lack of external validation from another constitution.
In conclusion, our study demonstrated that C. sinensis infection and low age (<50 years) were independent predictors for OS of srHCC patients after hepatectomy. Our results provide important clinical information for srHCC with C. sinensis infection.
References
- 1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. pmid:33538338
- 2. Xu J, Hong J, Wang Y, Zhou L, Xu B, Si Y, et al. Prognostic Influence of Spontaneous Tumor Rupture in Patients With Hepatocellular Carcinoma After Hepatectomy: A Meta-Analysis of Observational Studies. Front Surg. 2021;8:769233. pmid:34869566
- 3. Yoshida H, Mamada Y, Taniai N, Uchida E. Spontaneous ruptured hepatocellular carcinoma. Hepatol Res. 2016;46(1):13–21. pmid:25631290
- 4. Kim JY, Lee JS, Oh DH, Yim YH, Lee HK. Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2012;24(6):640–5. pmid:22395224
- 5. Castells L, Moreiras M, Quiroga S, Alvarez-Castells A, Segarra A, Esteban R, et al. Hemoperitoneum as a first manifestation of hepatocellular carcinoma in western patients with liver cirrhosis: effectiveness of emergency treatment with transcatheter arterial embolization. Dig Dis Sci. 2001;46(3):555–62. pmid:11318532
- 6. Hermann RE, David TE. Spontaneous rupture of the liver caused by hepatomas. Surgery. 1973;74(5):715–9. pmid:4355109
- 7. Rossetto A, Adani GL, Risaliti A, Baccarani U, Bresadola V, Lorenzin D, et al. Combined approach for spontaneous rupture of hepatocellular carcinoma. World J Hepatol. 2010;2(1):49–51. pmid:21160956
- 8. Qian MB, Utzinger J, Keiser J, Zhou XN. Clonorchiasis. Lancet. 2016;387(10020):800–10. pmid:26299184
- 9. Young ND, Campbell BE, Hall RS, Jex AR, Cantacessi C, Laha T, et al. Unlocking the transcriptomes of two carcinogenic parasites, Clonorchis sinensis and Opisthorchis viverrini. PLoS Negl Trop Dis. 2010;4(6):e719. pmid:20582164
- 10. Young ND, Jex AR, Cantacessi C, Campbell BE, Laha T, Sohn WM, et al. Progress on the transcriptomics of carcinogenic liver flukes of humans—unique biological and biotechnological prospects. Biotechnol Adv. 2010;28(6):859–70. pmid:20673796
- 11. Jiang ZH, Wan XL, Lv GL, Zhang WW, Lin Y, Tang WQ, et al. High prevalence of Clonorchis sinensis infection in Guangxi, Southern China. Trop Med Health. 2021;49(1):6. pmid:33461625
- 12. Sun J, Xin H, Jiang Z, Qian M, Duan K, Chen Y, et al. High endemicity of Clonorchis sinensis infection in Binyang County, southern China. PLoS Negl Trop Dis. 2020;14(8):e0008540. pmid:32776933
- 13. Deng ZH, Fang YY, Zhang QM, Mao Q, Pei FQ, Liu MR. The control of clonorchiasis in Guangdong province, southern China. Acta Trop. 2020;202:105246. pmid:31672488
- 14. Kim HG, Han J, Kim MH, Cho KH, Shin IH, Kim GH, et al. Prevalence of clonorchiasis in patients with gastrointestinal disease: a Korean nationwide multicenter survey. World J Gastroenterol. 2009;15(1):86–94. pmid:19115472
- 15. Dong H, Zhao L, Sun H, Shang M, Lv G, Yu X, et al. Coinfection of Clonorchis sinensis and hepatitis B virus: clinical liver indices and interaction in hepatic cell models. Parasit Vectors. 2022;15(1):460. pmid:36510325
- 16. Qi Y, Hu J, Liang J, Hu X, Ma N, Xiang B. Clonorchis sinensis infection contributes to hepatocellular carcinoma progression in rat. Parasitol Res. 2022;121(12):3403–15. pmid:36266591
- 17. Li YK, Zhao JF, Yang CL, Zhan GH, Zhang J, Qin SD, et al. Effects of Clonorchis sinensis combined with Hepatitis B virus infection on the prognosis of patients with Hepatocellular Carcinoma following Hepatectomy. PLoS Negl Trop Dis. 2023;17(1):e0011012. pmid:36638133
- 18. Conner SC, Sullivan LM, Benjamin EJ, LaValley MP, Galea S, Trinquart L. Adjusted restricted mean survival times in observational studies. Stat Med. 2019;38(20):3832–60. pmid:31119770
- 19. Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661–79. pmid:26238958
- 20. Rana SS, Bhasin DK, Nanda M, Singh K. Parasitic infestations of the biliary tract. Curr Gastroenterol Rep. 2007;9(2):156–64. pmid:17418062.
- 21. Choi D, Lim JH, Lee KT, Lee JK, Choi SH, Heo JS, et al. Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea. J Hepatol. 2006;44(6):1066–73. pmid:16480786
- 22. Seisen T, Jamzadeh A, Leow JJ, Rouprêt M, Cole AP, Lipsitz SR, et al. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. JAMA Oncol. 2018;4(2):225–9. pmid:28837718
- 23. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–107. pmid:19757444
- 24. Shi Y, Jiang Z, Yang Y, Zheng P, Wei H, Lin Y, et al. Clonorchis sinensis infection and co-infection with the hepatitis B virus are important factors associated with cholangiocarcinoma and hepatocellular carcinoma. Parasitol Res. 2017;116(10):2645–9. pmid:28801696
- 25. Chen X, Li S, He L, Wang X, Liang P, Chen W, et al. Molecular characterization of severin from Clonorchis sinensis excretory/secretory products and its potential anti-apoptotic role in hepatocarcinoma PLC cells. PLoS Negl Trop Dis. 2013;7(12) pmid:24367717
- 26. Chen W, Ning D, Wang X, Chen T, Lv X, Sun J, et al. Identification and characterization of Clonorchis sinensis cathepsin B proteases in the pathogenesis of clonorchiasis. Parasit Vectors. 2015;8:647. pmid:26691339
- 27. Gao Y, Li Y, Liu X, Zhang T, Yu G, Wang Y, et al. High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China. Sci Rep. 2020;10(1):11749. pmid:32678224
- 28. Li W, Dong H, Huang Y, Chen T, Kong X, Sun H, et al. Clonorchis sinensis Co-infection Could Affect the Disease State and Treatment Response of HBV Patients. PLoS Negl Trop Dis. 2016;10(6):e0004806. pmid:27348302
- 29. Han XJ, Su HY, Shao HB, Xu K. Prognostic factors of spontaneously ruptured hepatocellular carcinoma. World J Gastroenterol. 2015;21(24):7488–94. pmid:26139994
- 30. Shin BS, Park MH, Jeon GS. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization. Acta Radiol. 2011;52(3):331–5. pmid:21498371
- 31. Jin YJ, Lee JW, Park SW, Lee JI, Lee DH, Kim YS, et al. Survival outcome of patients with spontaneously ruptured hepatocellular carcinoma treated surgically or by transarterial embolization. World J Gastroenterol. 2013;19(28):4537–44. pmid:23901230
- 32. Lee CR, Lim JH, Kim SH, Ahn SH, Park YN, Choi GH, et al. A comparative analysis of hepatocellular carcinoma after hepatic resection in young versus elderly patients. J Gastrointest Surg. 2012;16(9):1736–43. pmid:22810298
- 33. Hung HH, Chiou YY, Hsia CY, Su CW, Chou YH, Chiang JH, et al. Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol. 2011;9(1):79–86. Epub 2010/09/14. pmid:20831902
- 34. Nathan H, Schulick RD, Choti MA, Pawlik TM. Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg. 2009;249(5):799–805. pmid:19387322
- 35. Zheng J, Seier K, Gonen M, Balachandran VP, Kingham TP, D’Angelica MI, et al. Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma. Ann Surg Oncol. 2017;24(12):3706–14. pmid:28840521
- 36. Zeng J, Lin K, Liu H, Huang Y, Guo P, Zeng Y, et al. Prognosis Factors of Young Patients Undergoing Curative Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Multicenter Study. Cancer Manag Res. 2020;12:6597–606. pmid:32848453
- 37. Ha SY, Sohn I, Hwang SH, Yang JW, Park CK. The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients. Oncotarget. 2015;6(21):18664–73. pmid:26093092
- 38. Cho SJ, Yoon JH, Hwang SS, Lee HS. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? J Gastroenterol Hepatol. 2007;22(8):1226–31. pmid:17498220
- 39. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9. pmid:28094848